194 related articles for article (PubMed ID: 37879679)
21. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560
[TBL] [Abstract][Full Text] [Related]
23. Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports.
Jørgensen L; Gøtzsche PC; Jefferson T
Syst Rev; 2020 Feb; 9(1):43. PubMed ID: 32106879
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
Kann H; Hortlund M; Eklund C; Dillner J; Faust H
Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.
Setiawan D; Luttjeboer J; Pouwels KB; Wilschut JC; Postma MJ
Jpn J Clin Oncol; 2017 Mar; 47(3):265-276. PubMed ID: 28042137
[TBL] [Abstract][Full Text] [Related]
26. The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap.
Cameron RL; Kavanagh K; Cameron Watt D; Robertson C; Cuschieri K; Ahmed S; Pollock KG
J Epidemiol Community Health; 2017 Oct; 71(10):954-960. PubMed ID: 28756395
[TBL] [Abstract][Full Text] [Related]
27. Expression of p16
Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
[TBL] [Abstract][Full Text] [Related]
28. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
[TBL] [Abstract][Full Text] [Related]
29. Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types.
Ryser M; Berlaimont V; Karkada N; Mihalyi A; Rappuoli R; van der Most R
Expert Rev Vaccines; 2019 Mar; 18(3):309-322. PubMed ID: 30739514
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Porras C; Tsang SH; Herrero R; Guillén D; Darragh TM; Stoler MH; Hildesheim A; Wagner S; Boland J; Lowy DR; Schiller JT; Schiffman M; Schussler J; Gail MH; Quint W; Ocampo R; Morales J; Rodríguez AC; Hu S; Sampson JN; Kreimer AR;
Lancet Oncol; 2020 Dec; 21(12):1643-1652. PubMed ID: 33271093
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
Arbyn M; Xu L
Expert Rev Vaccines; 2018 Dec; 17(12):1085-1091. PubMed ID: 30495978
[TBL] [Abstract][Full Text] [Related]
32. Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.
Zhu FC; Hu SY; Hong Y; Hu YM; Zhang X; Zhang YJ; Pan QJ; Zhang WH; Zhao FH; Zhang CF; Yang X; Yu JX; Zhu J; Zhu Y; Chen F; Zhang Q; Wang H; Wang C; Bi J; Xue S; Shen L; Zhang YS; He Y; Tang H; Karkada N; Suryakiran P; Bi D; Struyf F
Cancer Med; 2019 Oct; 8(14):6195-6211. PubMed ID: 31305011
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis.
Lin R; Jin H; Fu X
Expert Rev Vaccines; 2023; 22(1):1168-1178. PubMed ID: 37990881
[TBL] [Abstract][Full Text] [Related]
34. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis.
Bartels HC; Postle J; Rogers AC; Brennan D
Int J Gynecol Cancer; 2020 Jun; 30(6):777-782. PubMed ID: 32276936
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.
Lu B; Kumar A; Castellsagué X; Giuliano AR
BMC Infect Dis; 2011 Jan; 11():13. PubMed ID: 21226933
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Corona Gutierrez CM; Tinoco A; Navarro T; Contreras ML; Cortes RR; Calzado P; Reyes L; Posternak R; Morosoli G; Verde ML; Rosales R
Hum Gene Ther; 2004 May; 15(5):421-31. PubMed ID: 15144573
[TBL] [Abstract][Full Text] [Related]
38. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis.
La Torre G; de Waure C; Chiaradia G; Mannocci A; Ricciardi W
Vaccine; 2007 Dec; 25(50):8352-8. PubMed ID: 17996990
[TBL] [Abstract][Full Text] [Related]
39. Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review.
Bottari F; Iacobone AD; Passerini R; Preti EP; Sandri MT; Cocuzza CE; Gary DS; Andrews JC
Obstet Gynecol; 2019 Sep; 134(3):452-462. PubMed ID: 31403602
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
